Variant report
Variant | nsv561634 |
---|---|
Chromosome Location | chr13:51065836-51074693 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:20)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr13:51068926-51068942 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CTCF | chr13:51066171-51066200 | Lung_OC | lung: | n/a | n/a |
3 | E2F4 | chr13:51066794-51066832 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | JUND | chr13:51068432-51068493 | K562 | blood: | n/a | n/a |
5 | MAZ | chr13:51066308-51066416 | HepG2 | liver: | n/a | n/a |
6 | POLR2A | chr13:51065805-51065838 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | SPI1 | chr13:51068268-51068591 | HL-60 | blood: | n/a | n/a |
8 | SPI1 | chr13:51068156-51068803 | HL-60 | blood: | n/a | n/a |
9 | ZC3H11A | chr13:51068226-51068342 | K562 | blood: | n/a | n/a |
No data |
No data |
(count:20 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | NONHSAT033819 |
2 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | NONHSAT033850 |
3 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | NR_109974 |
4 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | NONHSAT033817 |
5 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | NONHSAT140131 |
6 | lnc-RNASEH2B-3 | chr13:51066780-51066897 | NONHSAT033861 |
7 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | XLOC_010390 |
8 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | XLOC_010390 |
9 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | NONHSAT033812 |
10 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | NONHSAT033815 |
11 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | XLOC_010390 |
12 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | NONHSAT033846 |
13 | lnc-RNASEH2B-3 | chr13:51067608-51067670 | NONHSAT033856 |
14 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | NONHSAT033855 |
15 | lnc-RNASEH2B-3 | chr13:51066787-51067189 | NONHSAT033842 |
16 | lnc-RNASEH2B-3 | chr13:51069312-51069605 | NONHSAT033856 |
17 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | NONHSAT033856 |
18 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | NONHSAT033821 |
19 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | NONHSAT033827 |
20 | lnc-RNASEH2B-3 | chr13:51066787-51066897 | NONHSAT033825 |
No data |
No data |
Variant related genes | Relation type |
---|---|
DLEU1 | TF binding region |
NAGK | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201762 | chr13:51065836-51065837 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs566398967 | chr13:51065847-51065848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs149889 | chr13:51065854-51065855 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs142068046 | chr13:51065870-51065871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559826343 | chr13:51065872-51065873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs530316191 | chr13:51065909-51065910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115374041 | chr13:51065932-51065933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs530915330 | chr13:51065965-51065966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555028809 | chr13:51065970-51065971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs987086 | chr13:51065987-51065988 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs184522294 | chr13:51065999-51066000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs199919750 | chr13:51066006-51066007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1262782 | chr13:51066063-51066064 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs73184405 | chr13:51066075-51066076 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs557214353 | chr13:51066091-51066092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534121162 | chr13:51066119-51066120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575461971 | chr13:51066124-51066125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs145738853 | chr13:51066148-51066149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372964917 | chr13:51066161-51066162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs5803515 | chr13:51066162-51066163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs33990643 | chr13:51066163-51066164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1262781 | chr13:51066171-51066172 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs138676961 | chr13:51066182-51066183 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs189444862 | chr13:51066227-51066228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555309931 | chr13:51066244-51066245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574818536 | chr13:51066262-51066263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs79306556 | chr13:51066263-51066264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528362416 | chr13:51066309-51066310 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs563550133 | chr13:51066314-51066315 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs531051655 | chr13:51066368-51066369 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs191852684 | chr13:51066377-51066378 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs73502137 | chr13:51066389-51066390 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs574006811 | chr13:51066443-51066444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543032583 | chr13:51066472-51066473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528568355 | chr13:51066485-51066486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546693665 | chr13:51066529-51066530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568435821 | chr13:51066577-51066578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs529202918 | chr13:51066584-51066585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550850003 | chr13:51066588-51066589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs1262780 | chr13:51066592-51066593 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs1262779 | chr13:51066604-51066605 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs1262778 | chr13:51066623-51066624 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
43 | rs566462221 | chr13:51066629-51066630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs113452989 | chr13:51066645-51066646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs564370060 | chr13:51066646-51066647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184277713 | chr13:51066663-51066664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs573261619 | chr13:51066668-51066669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543795559 | chr13:51066685-51066686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149254359 | chr13:51066686-51066687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1262777 | chr13:51066734-51066735 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Mental retardation | 17502991 | CNVD |
Retinoblastoma | 17502991 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Liposarcoma | 21253554 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cervical cancer | 21062161 | CNVD |
microdeletion syndrome | 19284877 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21858162 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hereditary prostate cancer | 22028916 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Prostate cancer | 17217626 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21990379 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:51065600-51068600 | Weak transcription | HepG2 | liver |
2 | chr13:51067200-51068000 | Enhancers | Dnd41 | blood |
3 | chr13:51067600-51069400 | Enhancers | Fetal Thymus | thymus |
4 | chr13:51067800-51068000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr13:51067800-51068200 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
6 | chr13:51067800-51068400 | Enhancers | K562 | blood |
7 | chr13:51067800-51069000 | Enhancers | Primary hematopoietic stem cells | blood |
8 | chr13:51067800-51069200 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr13:51067800-51069200 | Enhancers | Thymus | Thymus |
10 | chr13:51068000-51068200 | Flanking Active TSS | Dnd41 | blood |
11 | chr13:51068000-51068600 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
12 | chr13:51068000-51068600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr13:51068000-51069200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
14 | chr13:51068000-51069400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
15 | chr13:51068200-51068400 | Enhancers | Dnd41 | blood |
16 | chr13:51068200-51068800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr13:51068200-51069200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
18 | chr13:51068200-51069200 | Enhancers | Primary T cells from cord blood | blood |
19 | chr13:51068400-51068600 | Flanking Active TSS | Dnd41 | blood |
20 | chr13:51068400-51068800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
21 | chr13:51068600-51070000 | Enhancers | Dnd41 | blood |
22 | chr13:51069000-51069400 | Enhancers | Adipose Nuclei | Adipose |